Irbesartan Waymade

Irbesartan, the active ingredient in Irbesartan Waymade, is an Angiotensin II receptor blocker (ARB) presented as an oral dosage form for oral use. It is used to manage high blood pressure and to protect kidney function in patients with diabetic nephropathy. GNH USA supplies Irbesartan Waymade as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Irbesartan belongs to the class of Angiotensin II receptor blockers and is employed in conditions where inhibition of the renin‑angiotensin system is beneficial.

Hypertension: lowers elevated blood pressure and reduces cardiovascular risk. Diabetic nephropathy: slows progression of kidney damage in patients with type 2 diabetes.

Common Side Effects: - Dizziness or light‑headedness - Headache - Fatigue or tiredness - Nausea or abdominal discomfort - Back pain - Upper respiratory tract infection

Serious or Rare Side Effects: - Angioedema (swelling of face, lips, tongue) - Severe hyperkalemia (high blood potassium) - Acute kidney injury or worsening renal function - Hepatic injury (elevated liver enzymes) - Significant hypotension - Anaphylactic reactions

Before initiating therapy, clinicians should assess renal function, electrolyte status, and blood pressure.

Monitor blood pressure regularly: adjust dose based on response. Check renal function: baseline and periodic serum creatinine. Monitor serum potassium: especially if using potassium‑sparing agents. Use caution in hepatic impairment: dose may need adjustment. Avoid use in pregnancy: potential fetal harm. Store at below 25°C: keep in the original pack, protect from moisture.

Irbesartan may interact with several drug classes, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Concomitant aliskiren in diabetic patients: increased risk of renal impairment. - Dual therapy with ACE inhibitors or other ARBs: heightened risk of hyperkalemia and renal dysfunction. - Potassium‑sparing diuretics (e.g., spironolactone): may cause severe hyperkalemia. - Lithium: increased lithium levels and toxicity. - NSAIDs (high dose): can reduce antihypertensive effect and impair renal function.

Moderate Interactions (Monitor Closely): - Thiazide diuretics: additive blood‑pressure lowering effect. - CYP3A4 inhibitors (e.g., ketoconazole): may increase irbesartan plasma concentrations. - NSAIDs (low dose): monitor renal function and electrolytes. - Other antihypertensives: watch for excessive hypotension. - Antidiabetic agents: blood‑glucose may improve, requiring dose adjustment.